OS Therapies (OSTX) Preferred Shares (2023 - 2024)
OS Therapies' (OSTX) quarterly Preferred Shares came in at $4.1 million in Q4 2024, up 313112.37% YoY from N/an in Q1 2024, and up 313112.37% on a QoQ basis from $1302.0 in Q4 2023.
OS Therapies (OSTX) Preferred Shares (2023 - 2024) Analysis & Trends
OS Therapies (OSTX) has 2 years of Preferred Shares data on file, last reported at $4.1 million in Q4 2024.
- Quarterly Preferred Shares rose 313112.37% year-over-year to $4.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $4.1 million (up 313112.37% YoY) and the FY2024 annual result came in at $4.1 million, up 313112.37% from the prior year.
- Preferred Shares climbed to $4.1 million in Q4 2024, from $1302.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $4.1 million in Q4 2024 to a low of $1302.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | - |
| 10 | OS Therapies | 19.48 Mn | 19.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 4.08 Mn |
| Dec 31, 2023 | 1,302.00 |